시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 단순 요로감염 시장 보고서(2025년)
Uncomplicated Urinary Tract Infection Global Market Report 2025
상품코드 : 1751148
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

단순 요로감염 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 6.8%의 성장률로 142억 7,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 세균 감염 증가, 인구 고령화, 성행위 증가, 요로 감염 증가, 피임약 사용 증가에 기인합니다. 이 기간의 주요 동향으로는 원격의료의 개발, 원격의료 솔루션의 주요 발전, 신약의 창출, 요로 감염 치료제의 발전, 연구개발의 지속적인 진전 등이 있습니다.

만성 신장병(CKD)의 유병률 증가는 단순 요로감염(UTI) 시장의 성장을 견인할 것으로 예상되며, 만성 신장병(CKD)은 신장이 점차 기능을 잃어 체내에 노폐물과 체액이 축적되는 장기적인 질환으로, CKD 환자의 증가는 당뇨병 유병률 증가가 주요 원인으로 작용하고 있습니다. 장기간의 고혈당증은 신장에 손상을 입혀 노폐물을 제대로 걸러내는 능력을 손상시키고, CKD는 면역 체계를 약화시켜 요로 감염에 걸리기 쉽습니다. 또한, 신장 기능이 저하되면 소변이 정체되기 쉬워 세균이 번식하기 좋은 환경이 됩니다. 예를 들어, 2023년 6월 Kidney Research UK는 영국에서 만성 신장 질환으로 인한 신장 이식이 증가하여 2021년 2,863건에서 2023년 2,976건으로 증가했다고 보고했습니다. 따라서 만성 신장 질환의 비율 증가는 합병증 없는 요로 감염 시장의 성장을 촉진할 것으로 예상됩니다.

당뇨병 유병률의 증가는 단순 요로감염 시장의 성장을 촉진할 것으로 예상됩니다. 당뇨병은 인슐린 분비 부족이나 인슐린 이용 부족으로 인한 고혈당을 특징으로 하는 만성 대사 질환입니다. 당뇨병 환자의 증가는 식습관 및 운동 부족과 같은 건강에 해로운 생활습관에 기인하는 바가 큽니다. 가공식품과 당분이 많은 식품의 섭취 증가와 앉아서 생활하는 습관이 제2형 당뇨병의 주요 위험요인인 비만율의 증가를 초래하고 있습니다. 혈당 상승은 요로 세균 증식을 촉진하고 요로 결석 발생률을 높입니다. 또한 당뇨병은 면역 체계를 약화시켜 요로 결석을 포함한 감염에 대항하는 것을 더 어렵게 만듭니다. 예를 들어, 2024년 3월 OHID(Office for Health Improvement &Disparities)는 영국에서 1형 당뇨병 환자가 필요한 8가지 치료 과정을 모두 받은 비율은 1년 만에 35.2%에서 43.8%로 증가했다고 보고했습니다. 증가했다고 보고했습니다. 이에 따라 당뇨병 환자의 증가는 단순 요로감염 시장의 성장을 촉진할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

An uncomplicated urinary tract infection (UTI) is a bacterial infection of the bladder or urethra that typically occurs in healthy individuals without any structural issues or underlying health conditions. It most commonly affects the bladder (cystitis) and is caused by common uropathogens, such as Escherichia coli (E. coli). The primary goals of diagnosis and treatment are to relieve symptoms, prevent complications, and eradicate the infection using short-course antibiotics, ensuring a quick recovery without long-term effects.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main diagnostic tests in the uncomplicated urinary tract infection market include urinalysis, urine cultures, and susceptibility testing. Urinalysis is a laboratory test that analyzes a urine sample to detect and measure various substances, such as proteins, glucose, red and white blood cells, and bacteria. The market also includes a range of drugs, such as penicillin and its combinations, quinolones, cephalosporins, azoles and amphotericin B, nitrofurans, and others, along with various end-users such as hospitals, diagnostic labs, and research institutes.

The uncomplicated urinary tract infection market research report is one of a series of new reports from The Business Research Company that provides uncomplicated urinary tract infection market statistics, including uncomplicated urinary tract infection industry global market size, regional shares, competitors with an uncomplicated urinary tract infection market share, detailed uncomplicated urinary tract infection market segments, market trends and opportunities, and any further data you may need to thrive in the uncomplicated urinary tract infection industry. This uncomplicated urinary tract infection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The uncomplicated urinary tract infection market size has grown strongly in recent years. It will grow from $10.24 billion in 2024 to $10.98 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth observed during the historic period can be attributed to the increasing cases of renal failure, rising instances of bladder cancer, a higher prevalence of chronic kidney diseases, a growing use of urinary catheters, and the rising prevalence of diabetes.

The uncomplicated urinary tract infection market size is expected to see strong growth in the next few years. It will grow to $14.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth projected during the forecast period can be attributed to the rise in bacterial infections, an aging population, increased sexual activity, a growing number of urinary tract infections, and the rising use of contraceptives. Key trends during this period include the development of telemedicine, advancements in telehealth solutions, the creation of novel drugs, progress in urinary tract infection therapeutics, and continued advancements in research and development.

The growing prevalence of chronic kidney diseases (CKD) is expected to drive the expansion of the uncomplicated urinary tract infection (UTI) market. CKD is a long-term condition where the kidneys gradually lose their function, causing waste and fluid to build up in the body. The rise in CKD cases is largely attributed to the increasing prevalence of diabetes, as high blood sugar over time can damage the kidneys, impairing their ability to filter waste properly. CKD weakens the immune system, making individuals more vulnerable to urinary tract infections. Furthermore, poor kidney function can lead to urine retention, creating an environment conducive to bacterial growth. For example, in June 2023, Kidney Research UK reported an increase in kidney transplants in the UK due to chronic kidney disease, with the number rising from 2,863 transplants in 2021 to 2,976 in 2023. Therefore, the increasing rates of chronic kidney diseases are expected to fuel the growth of the uncomplicated urinary tract infection market.

The rising incidence of diabetes is expected to drive the growth of the uncomplicated urinary tract infection market. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels due to insufficient insulin production or poor insulin utilization. The rise in diabetes cases is largely due to unhealthy lifestyle habits, such as poor diet and lack of physical activity. The increased consumption of processed foods and sugary products, along with sedentary behavior, has contributed to higher obesity rates, a major risk factor for type 2 diabetes. Elevated blood sugar levels foster bacterial growth in the urinary tract, leading to a higher incidence of UTIs. Moreover, diabetes can compromise the immune system, making it more difficult for the body to combat infections, including UTIs. For instance, in March 2024, the Office for Health Improvement & Disparities (OHID) reported that in England, the percentage of individuals with Type 1 diabetes receiving all eight required care processes increased from 35.2% to 43.8% in just one year. Consequently, the rising cases of diabetes are expected to drive the growth of the uncomplicated urinary tract infection market.

Key companies in the uncomplicated urinary tract infection (UTI) market are focusing on developing new antibiotics to improve treatment effectiveness and address the challenge of antibiotic-resistant bacteria. Antibiotics work by killing or inhibiting the growth of bacteria in the body to treat infections. For example, in April 2024, the U.S. Food and Drug Administration (FDA) approved Pivya (pivmecillinam) tablets for the treatment of uncomplicated urinary tract infections in adult females. This tablet targets UTIs caused by susceptible strains of Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus. Pivmecillinam is a prodrug that converts into mecillinam, a beta-lactam antibiotic that works by disrupting the cell wall synthesis of gram-negative bacteria. These advancements in antibiotic development are strengthening the effectiveness of UTI treatments.

Major players in the uncomplicated urinary tract infection market are Cardinal Health, Pfizer Inc., Bayer AG, AstraZeneca plc, GSK plc, Eli Lilly and Company, Siemens AG, Strykar Healthcare, John Hopkins Medicine, Shionogi & Co. Ltd., Sysmex Corporation, Bio-Rad Laboratories Inc, Cipla Inc., UTILITY therapeutics Ltd, Orchid Pharma Limited, ACON Labs, Sonika Lifesciences, Emergency Care BC, EB Medicine, Iterum Therapeutics PLC.

North America was the largest region in the uncomplicated urinary tract infection market in 2024. The regions covered in uncomplicated urinary tract infection report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the uncomplicated urinary tract infection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The uncomplicated urinary tract infection market consists of sales of urinary analgesics, pH-altering agents, and hydration and supportive supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uncomplicated Urinary Tract Infection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on uncomplicated urinary tract infection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for uncomplicated urinary tract infection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The uncomplicated urinary tract infection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Uncomplicated Urinary Tract Infection Market Characteristics

3. Uncomplicated Urinary Tract Infection Market Trends And Strategies

4. Uncomplicated Urinary Tract Infection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Uncomplicated Urinary Tract Infection Growth Analysis And Strategic Analysis Framework

6. Uncomplicated Urinary Tract Infection Market Segmentation

7. Uncomplicated Urinary Tract Infection Market Regional And Country Analysis

8. Asia-Pacific Uncomplicated Urinary Tract Infection Market

9. China Uncomplicated Urinary Tract Infection Market

10. India Uncomplicated Urinary Tract Infection Market

11. Japan Uncomplicated Urinary Tract Infection Market

12. Australia Uncomplicated Urinary Tract Infection Market

13. Indonesia Uncomplicated Urinary Tract Infection Market

14. South Korea Uncomplicated Urinary Tract Infection Market

15. Western Europe Uncomplicated Urinary Tract Infection Market

16. UK Uncomplicated Urinary Tract Infection Market

17. Germany Uncomplicated Urinary Tract Infection Market

18. France Uncomplicated Urinary Tract Infection Market

19. Italy Uncomplicated Urinary Tract Infection Market

20. Spain Uncomplicated Urinary Tract Infection Market

21. Eastern Europe Uncomplicated Urinary Tract Infection Market

22. Russia Uncomplicated Urinary Tract Infection Market

23. North America Uncomplicated Urinary Tract Infection Market

24. USA Uncomplicated Urinary Tract Infection Market

25. Canada Uncomplicated Urinary Tract Infection Market

26. South America Uncomplicated Urinary Tract Infection Market

27. Brazil Uncomplicated Urinary Tract Infection Market

28. Middle East Uncomplicated Urinary Tract Infection Market

29. Africa Uncomplicated Urinary Tract Infection Market

30. Uncomplicated Urinary Tract Infection Market Competitive Landscape And Company Profiles

31. Uncomplicated Urinary Tract Infection Market Other Major And Innovative Companies

32. Global Uncomplicated Urinary Tract Infection Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Uncomplicated Urinary Tract Infection Market

34. Recent Developments In The Uncomplicated Urinary Tract Infection Market

35. Uncomplicated Urinary Tract Infection Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기